Management of Alcohol Withdrawal

Primary Recommendations

The American Association for the Study of Liver Diseases recommends lorazepam as the preferred first-line agent for alcohol withdrawal management, particularly in patients with liver disease, advanced age, or serious medical comorbidities, though phenobarbital shows promise as an effective alternative that may reduce hospital length of stay 1, 2, 3

Benzodiazepines are the gold standard for alcohol withdrawal syndrome (AWS) treatment due to their proven efficacy in preventing seizures, delirium tremens, and reducing withdrawal symptoms through GABA activation 1, 2, 3
The American College of Gastroenterology recommends benzodiazepines as first-line treatment for AWS, with lorazepam being preferred in patients with severe liver disease or cirrhosis, advanced age, recent head trauma, respiratory failure, obesity, or other serious medical comorbidities 1
The dosing of lorazepam should start at 6-12 mg/day (1-4 mg every 4-8 hours), then taper following symptom resolution 1

The American Society of Addiction Medicine recommends long-acting benzodiazepines, such as chlordiazepoxide or diazepam, as preferred for most patients without liver disease, due to their superior seizure and delirium tremens protection 4, 5
Chlordiazepoxide should be administered at 25-100 mg every 4-6 hours (maximum 300 mg in first 24 hours) 1, 4
Diazepam should be administered at 5-10 mg IV/IM every 6-8 hours 1, 5

Thiamine 100-300 mg/day MUST be administered to ALL patients to prevent Wernicke encephalopathy, continued for 2-3 months after symptom resolution, according to the National Institute on Alcohol Abuse and Alcoholism 1, 2, 3, 4, 5
Thiamine should be administered BEFORE any glucose-containing IV fluids, as glucose administration can precipitate acute thiamine deficiency 1, 4

The Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scores should be used to guide dosing intensity, with scores >8 indicating moderate withdrawal and ≥15 indicating severe withdrawal requiring aggressive treatment 4, 5
Vital signs should be monitored frequently for autonomic instability (fever, tachycardia, hypertension, sweating) 1
Monitoring should continue for 24 hours even without symptoms to ensure no seizure development 2, 3

Over 70% of cirrhotic patients do not require pharmacological withdrawal treatment, according to the European Association for the Study of the Liver, and should only be treated if symptomatic 2, 3
When treatment is necessary, lorazepam or oxazepam (short-acting agents) should be prioritized to avoid accumulation 2, 3
Symptom-adapted dosing should be used rather than fixed schedules 2, 3

Anticonvulsants should never be used alone for alcohol withdrawal seizures, and benzodiazepines are required, as stated by the American Epilepsy Society 4
Gabapentin should not be substituted for benzodiazepines in moderate-to-severe AWS, due to inadequate symptom control and increased seizure/delirium tremens risk 4
Treatment duration should not exceed 10-14 days to prevent benzodiazepine dependence, according to the American Society of Addiction Medicine 5
The CIWA protocol should not be used for diagnosis, as high scores can occur in anxiety disorders, sepsis, hepatic encephalopathy, and severe pain 1

Carbamazepine 200 mg every 6-8 hours is effective for seizure prevention as a benzodiazepine alternative, according to the National Institute of Neurological Disorders and Stroke 1, 4
Baclofen and topiramate show promise for both withdrawal management and relapse prevention, though evidence remains preliminary, as stated by the National Institute on Alcohol Abuse and Alcoholism 4